BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33221954)

  • 1. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
    Fayad C; Audi H; Khnayzer RS; Daher CF
    J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photoactivatable Ru (II) complex bearing 2,9-diphenyl-1,10-phenanthroline: A potent chemotherapeutic drug inducing apoptosis in triple negative human breast adenocarcinoma cells.
    Mansour N; Bodman-Smith K; Khnayzer RS; Daher CF
    Chem Biol Interact; 2021 Feb; 336():109317. PubMed ID: 33197429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
    Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
    J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-apoptotic activity of ruthenium 1-methylimidazole complex on non-small cell lung cancer.
    Dias JSM; Silva HVR; Ferreira-Silva GÁ; Ionta M; Corrêa CC; Almeida F; Colina-Vegas L; Barbosa MIF; Doriguetto AC
    J Inorg Biochem; 2018 Oct; 187():1-13. PubMed ID: 30015231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
    Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
    J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytotoxicity, cellular uptake, reactive oxygen species and cell cycle arrest studies of novel ruthenium(II) polypyridyl complexes towards A549 lung cancer cell line.
    Qasim Warraich M; Ghion A; Perdisatt L; O'Neill L; Casey A; O'Connor C
    Drug Chem Toxicol; 2021 May; 44(3):319-329. PubMed ID: 30991856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A photoactivatable chemotherapeutic Ru(II) complex bearing bathocuproine ligand efficiently induces cell death in human malignant melanoma cells through a multi-mechanistic pathway.
    Elias MG; Mehanna S; Elias E; Khnayzer RS; Daher CF
    Chem Biol Interact; 2021 Oct; 348():109644. PubMed ID: 34508709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
    Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
    Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
    Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
    J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
    Heinemann F; Karges J; Gasser G
    Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
    Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
    J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
    Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes.
    Lari M; Martínez-Alonso M; Busto N; Manzano BR; Rodríguez AM; Acuña MI; Domínguez F; Albasanz JL; Leal JM; Espino G; García B
    Inorg Chem; 2018 Nov; 57(22):14322-14336. PubMed ID: 30379535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Sep; 220():117132. PubMed ID: 31146211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
    Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
    Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
    Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
    Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.